Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Currently there is debate on whether hypoglycemia is an independent risk factor for atherosclerosis, but little attention has been paid to the effects of recovery from hypoglycemia. In normal control individuals and in people with type 1 diabetes, recovery from a 2-h induced hypoglycemia was obtained by reaching normoglycemia or hyperglycemia for another 2 h and then maintaining normal glycemia for the following 6 h. Hyperglycemia after hypoglycemia was also repeated with the concomitant infusion of vitamin C. Recovery with normoglycemia is accompanied by a significant improvement in endothelial dysfunction, oxidative stress, and inflammation, which are affected by hypoglycemia; however, a period of hyperglycemia after hypoglycemia worsens all of these parameters, an effect that persists even after the additional 6 h of normoglycemia. This effect is partially counterbalanced when hyperglycemia after hypoglycemia is accompanied by the simultaneous infusion of vitamin C, suggesting that when hyperglycemia follows hypoglycemia, an ischemia–reperfusion-like effect is produced. This study shows that the way in which recovery from hypoglycemia takes place in people with type 1 diabetes could play an important role in favoring the appearance of endothelial dysfunction, oxidative stress, and inflammation, widely recognized cardiovascular risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, these agents promote hemodynamic equilibrium,18 diminish thrombotic propensity,448 alleviate endothelial oxidative stress,449 attenuate inflammatory processes,450 and foster a favorable balance of the gut microbiota,451 all of which collectively contribute to the salutary effects of these agents in patients with AS.”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [449]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 2×
“(ACCORD) trial (18) and possibly in the Veterans Affairs Diabetes Trial (VADT) (19) and Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) (20) studies has caused concern, because intensive treatment had tripled the frequency of severe hypoglycemia.”
BackgroundCorretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D., Charbonneau, F., Creager, M. A., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01746-6 · Cited by 4,604
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“in individuals with type 1 diabetes were within normal reference ranges (10), and they did not exhibit hypoglycemia unawareness, as based on the methods of Gold et al.”
MethodGold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Suh, S. W., Gum, E. T., Hamby, A. M., Chan, P. H., & Swanson, R. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30077 · Cited by 419 · cited 3×
“There is, however, evidence that free radical production rises, not only during hypoglycemia but particularly during glucose reperfusion after hypoglycemia (9).”
BackgroundResultDetection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress
Mercuri, F., Tonutti, L., Taboga, C., Ceriello, A., Assaloni, R., Motz, E., & Quagliaro, L. (2001) · Diabetologia · doi:10.1007/s001250100529 · Cited by 419 · cited 1×
“Cholesterol, triglycerides, HDL and LDL cholesterol, and plasma nitrotyrosine were measured as previously described (14).”
MethodSelf-citationCeriello, A., Ihnat, M. A., & Thorpe, J. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1824 · Cited by 413 · cited 2×
“The concept of “legacy” or “metabolic memory” is well recognized in hyperglycemia and indicates the possibility of a long-lasting deleterious effect persisting for some time after glucose normalization (23).”
BackgroundSelf-citation
Cited by
Items 101–156 of 156
Tynjälä, A., Harjutsalo, V., Sigfrids, F. J., Groop, P., Gordin, D., & the FinnDiane Study Group (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01770-2 · Cited by 10
Storino-Farina, M. A., Contreras, M. A., Rojano, J., Serrano, R., & Nouel, A. N. (2014) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2014.09.004 · Cited by 9
Merchant, H. J., Forteath, C., Gallagher, J. R., Dinkova‐Kostova, A. T., Ashford, M. L. J., McCrimmon, R. J., & McNeilly, A. D. (2025) · Antioxidants · doi:10.3390/antiox14030308 · Cited by 9
“Glucose reperfusion in end-organs is a significant source of ROS [4,27].”
Gómez, A., Henao, D. C., Taboada, L. B., Fuentes, O., Lucero, O. J. M., Sanko, A. A., Ma, R., Múñoz, Ó., Rondón, M., García-Jaramillo, M., et al. (2021) · Medical Devices Evidence and Research · doi:10.2147/mder.s288526 · Cited by 11
D’Amato, G., Ciccone, M. M., Faienza, M. F., Scicchitano, P., Lamparelli, R., Zaza, P., Cecere, A., Brunetti, G., Cortese, F., Valente, F., et al. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1523-7574 · Cited by 8
Challenges in hyperglycemia management in critically ill patients with COVID-19
Kethireddy, R., Gandhi, D., Kichloo, A., & Patel, L. A. (2022) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v11.i4.219 · Cited by 9
Anfinogenova, Y., Grakova, E. V., Shvedova, M., Kopeva, K. V., Teplyakov, A. T., & Popov, S. V. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9647-y · Cited by 8
Schönenberger, K. A., Ferreira, A., Stebler, C., Prendin, F., Gawinecka, J., Nakas, C. T., Mühlebach, S., Stanga, Z. G., Facchinetti, A., Herzig, D., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15175 · Cited by 9
Colinet, V., & Lysy, P. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.887976 · Cited by 7
Ünlütürk, U., Bahçecioğlu, A. B., Samadi, A., Lay, İ., Bayraktar, M., & Dağdelen, S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02110-7 · Cited by 6
“Several studies have shown that glycemic fluctuations might lead to oxidative stress by mechanisms independent of chronic hyperglycemia [13, 31, 32].”
BackgroundWidlansky, M. E., & Malik, M. A. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_8 · Cited by 8
Russell-Jones, D. L., Smout, V., Roy, S. S., Myers, G., Littlewood, R., & Shojaee‐Moradie, F. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70323 · Cited by 7
“18,29 Recurrent hypoglycaemia following initial treatment affects many individuals, contributing to treatment burden, healthcare utilisation, and patient anxiety.”
Johnston, C. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-66162-1.00009-3 · Cited by 8
Brain Regulation of Cardiac Function during Hypoglycemia
Chambers, M. E., Nuibe, E. H., & Reno, C. M. (2023) · Metabolites · doi:10.3390/metabo13101089 · Cited by 7
Glucose management in diabetic patients undergoing hemodialysis
Kishimoto, M., & Noda, M. (2014) · Diabetology International · doi:10.1007/s13340-014-0171-1 · Cited by 5
Glycemic Variability: Clinical and Prognostic Significance
Lin, K. Y. H., Huang, K.-J., & Yang, C. (2015) · Diabetes Research - Open Journal · doi:10.17140/droj-1-108 · Cited by 5
Cindro, P. V., Krnić, M., Modun, D., Smajić, B., & Vuković, J. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00746-1 · Cited by 7
“The impact of glucose variability on oxidative stress is relatively well established [3, 5, 21, 34, 35], but as the oxidative stress itself leads to the development of atherosclerosis through multiple mechanisms, it is a logical conclusion that GV should result also in the increase of arterial stiffness.”
BackgroundHu, Y., Li, Z., Li, H., Xu, Q., Xu, C., Lin, W., Ma, X., Hao, M., & Kuang, H. (2024) · Diabetes and Vascular Disease Research · doi:10.1177/14791641241278506 · Cited by 5
Ni, J., Chen, L., Su, H., Cai, J., Wang, C., Lu, W., Wang, Y., Lu, J., Xia, T., & Zhou, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70214 · Cited by 4
Przygodzki, T., Talar, M., & Watała, C. W. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.026 · Cited by 4
“Diabetes is an example of a pathophysiological condition, where endothelial function is affected (Schalkwijk and Stehouwer, 2005; Estrada et al., 2012; Ceriello et al., 2012).”
BackgroundMartyn-Nemeth, P. A., Birlingmair, R., Idemudia, E., & Park, C. (2019) · Nursing Open · doi:10.1002/nop2.267 · Cited by 5
“, 2014), en‐ dothelial dysfunction (Ceriello et al., 2012) and cardiovascular events (Yoon et al.”
BackgroundGrassi, B. A., Onetto, M. T., Zapata, Y., Jofré, P., & Echeverría, G. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.017 · Cited by 6
Harvengt, A., Pollé, O. G., Martin, M., Maanen, A. G. V., Gatto, L., & Lysy, P. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294982 · Cited by 3
Widlansky, M. E., & Malik, M. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_8-1 · Cited by 3
Glycemic Variability in Type 1 Diabetes—Does It Matter?
Schwartz, F., & Marling, C. R. (2014) · US Endocrinology · doi:10.17925/use.2014.10.01.20 · Cited by 3
The evolving frontier of diabetes therapy: The renaissance of glycemology
Ceriello, A., Genovese, S., & Bosi, E. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.036 · Cited by 3
Self-citationForteath, C., Merchant, H. J., Kocherry, C., Murdoch, C. E., Kerr, J., Gallagher, J. R., Evans, M. L., Thorens, B., Pedersen‐Bjergaard, U., de Galan, B. E., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06574-5 · Cited by 2
“Endothelial dysfunction arises from increased endothelin-1, reduced endothelial nitric oxide synthase (eNOS) activity and lower NO bioavailability, promoting vasoconstriction, hypertension, and left ventricular hypertrophy [28–31].”
Gholamzadeh, R., Bigdeli, M. R., Eskandari, M., & Mostafavi, H. (2018) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.5.347 · Cited by 2
“Stress response causes a further increase in blood glucose in hypoglycemia, compared to normoglycemia condition (Ceriello et al., 2012).”
Risk factors of pathological glycemic variability in pregnant women with type 1 diabetes mellitus
Tiselko, A. V. (2019) · Journal of obstetrics and women s diseases · doi:10.17816/jowd68341-50 · Cited by 2
Glycemic Control in Neurological Intensive Care Unit Patients
Krylov, K. Y., Савин, И. А., Sviridov, S. V., Vedenina, I. V., Petrova, M. V., Vorobyev, A. N., & Rubanes, M. (2021) · Clinical nutrition and metabolism · doi:10.17816/clinutr60533 · Cited by 1
Glucose Variability Measures in Critical Care
Sadan, O., & Hall, C. L. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87302-8_24-1 · Cited by 1
Seaquist, E. R., Giménez, M., Yan, Y., Matsuhisa, M., Kao, C. Y., Wadwa, R. P., Nagai, Y., & Khunti, K. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae034 · Cited by 1
“Posthypoglycemic hyperglycemia is associated with endothelial dysfunction, oxidative stress, and inflammation and has been shown to worsen thrombosis activation and endothelial damage in patients with T1D [14, 15].”
BackgroundYuriani, Y., Andrajati, R., & Pramono, L. A. (2019) · Indonesian Journal of Clinical Pharmacy · doi:10.15416/ijcp.2019.8.2.99 · Cited by 1
Xiong, Z., Xie, P., Li, J., Chen, Z.-C., Lin, Y., Liu, M., Zhang, S., Zhong, X., Zhou, H., Zhuang, X., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.687054 · Cited by 1
“A study in FG normal control individuals and in type 1 diabetes confirmed the effect of the way of recovering from hypoglycemia, since the progress induces endothelial dysfunction, oxidative stress, and inflammation, the deleterious effects of the recovering progress could be worsen when obtained reaching hyperglycemi…”
ResultCindro, P. V., Krnić, M., Modun, D., Vuković, J., Kurir, T. T., Kardum, G., Rušić, D., Perišin, A. Š., & Bukić, J. (2022) · JMIR Formative Research · doi:10.2196/35655 · Cited by 1
Hypoglycemia, insulin resistance, and cardiovascular disease: A possible link
Iqbal, A., Chaudhury, T., & Heller, S. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00028-1 · Cited by 1
Oxidative Stress in Pregnancies Complicated by Diabetes
Lappas, M., Leiva, A., Pardo, F., Sobrevía, L., & Jawerbaum, A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-1405-0_3 · Cited by 1
Malglycemia and health outcomes in hospitalized patients with Acute Myeloid Leukemia
Storey, S. (2015) · Cited by 1
Severe Dilated Cardiomyopathy in a Girl with Celiac Disease and Type 1 Diabetes
Ghédira, I. (2016) · Journal of Gastroenterology Pancreatology & Liver Disorders · doi:10.15226/2374-815x/3/3/00161
Monitoring of vascular health in children at risk for atherosclerosis.
Harrington, J. (2014) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Identification and characterization of biomarkers in atherosclerosis and diabetes
Nieddu, G., LEPEDDA, A. J., & FORMATO, M. (2014) · UnissResearch (Università degli Studi di Sassari)
Impacto cardiovascular de la hipoglicemia
Espitia, M. D. L. (2017) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.12.002 · Cited by 2
Bergevin, M. D. (2017) · TSpace (University of Toronto)
Kimura, M., Toyoda, M., Saito, N., Nakagawa, Y., & Fukagawa, M. (2017) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000768
Glucose control, cardiorespiratory fitness, and dietary composition in healthy men.
Moller, J. C. (2020) · SUNScholar (Stellenbosch University) · Cited by 1
Insulin Resistance and Metabolic Comorbidities in Alzheimer’s DiseasePreprint
Johansson, M. (2021) · medRxiv · doi:10.1101/2021.04.23.21255980
“Oxidative stress is an effect of both hyperglycaemia and inflammation and both depression and cognitive impairment (CI) is associated with higher values on the quantified homeostatic model (HOMA) used for assessing IR.9 The link between IR and CI goes through the hypothalamic-pituitary-adrenal (HPA) axis as its stress…”
MethodInfluentialGlucose Variability Measures in Critical Care
Sadan, O., & Hall, C. L. (2023) · Biomarkers in disease · doi:10.1007/978-3-031-07395-3_24 · Cited by 1
Adjunct Drug Treatment to Reduce Vascular Disease in People with Diabetes
Jenkins, A. J. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_29
Traiter les hypoglycémies iatrogènes à l’ère des nouvelles technologies
Monnier, L., & Colette, C. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.02.002
Cindro, P. V., Krnić, M., Modun, D., Smajić, B., & Vuković, J. (2021) · Figshare · doi:10.6084/m9.figshare.14516239
Jian, Y., Cheng, L., Hong, Y., Li, Z., Li, C., Ban, X., Zhu, L., & Gu, Z. (2025) · Food Nutrition · doi:10.1016/j.fnutr.2025.100048
Hippocampal Lipocalin-2 in T2DM Associated Neurodegeneration: A Therapeutic Perspective
Panigrahy, B., Mukherjee, A., & Singh, S. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04765-z
“Although physiological levels of ROS participate in normal cellular signalling, dysregulated glucose homeostasis leads to excessive ROS production, which drives pathological astrogliosis and subsequent LCN-2 upregulation [92] (Fig.”
Mechanism‐Informed Pharmacotherapy Optimization and Deprescribing: A Redox–Mitochondrial Framework
Martinc, B. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70313
Type 1 diabetes and cardiovascular medicine
Jenkins, A. J., Huang, M., Hemphill, M., Chen, D., Ha, J. T., Sata, Y., Sindone, A. P., Gnanenthiran, S. R., & Lan, N. S. R. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00338-9
“Hyperglycaemia, hypoglycaemia and glucose variability promote inflammation, oxidative stress, endothelial dysfunction and a pro-thrombotic state [25, 26].”
Metadata
- Authors
- Ceriello, A., Novials, A., Ortega, E., La Sala, L., Pujadas, G., Testa, R., Bonfigli, A. R., Esposito, K., & Giugliano, D.
- Affiliations
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Department of Endocrinology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Hospital Clínic de Barcelona (ES)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Corresponding author
- Ceriello, Antonio
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-10-16
- Volume
- 61
- Issue
- 11
- Pages
- 2993-2997
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3478543
- OpenAlex
- W2107614741
- Cited by
- 155
- References
- 25
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 11 · 2022: 9 · 2021: 16 · 2020: 17 · 2019: 14 · 2018: 12 · 2017: 10 · 2016: 14 · 2015: 12 · 2014: 14 · 2013: 9 · 2012: 2
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hypoglycemia, hyperglycemia, endothelial dysfunction, oxidative stress, inflammation, type 1 diabetes, vitamin C, ischemia-reperfusion, atherosclerosis risk, cardiovascular risk factors
- MeSH terms
- Adult, Antioxidants, Ascorbic Acid, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Endothelium, Vascular, Female, Glucose, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Infusions, Intravenous, Insulin, Male, Risk Factors, Vasodilation, Oxidative Stress, Cross-Over Studies, Inflammation Mediators, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.